Recent News

• 10.31.2025 - CORMEDIX INC. TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON NOVEMBER 12, 2025
• 10.23.2025 - CORMEDIX INC. RECEIVES INNOVATIVE TECHNOLOGY DESIGNATION FROM VIZIENT FOR DEFENCATH
• 10.20.2025 - CORMEDIX INC. ANNOUNCES PRELIMINARY THIRD QUARTER 2025 RESULTS AND RAISES 2025 NET REVENUE GUIDANCE
• 09.29.2025 - CORMEDIX ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE III RESPECT CLINICAL TRIAL FOR REZZAYO

Recent Filings

• 10.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.24.2025 - DEF 14A Other definitive proxy statements
• 10.20.2025 - 8-K Current report
• 10.20.2025 - EX-99.1 EX-99.1
• 10.14.2025 - PRER14A Preliminary Proxy Soliciting materials
• 10.07.2025 - S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
• 10.07.2025 - RW Registration Withdrawal Request
• 10.06.2025 - S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
• 10.06.2025 - RW Registration Withdrawal Request
• 09.30.2025 - 8-K/A Current report